Table 3.

Antimicrobial Susceptibility Profile of Gram-Positive Bacterial Isolates at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia, from January to August, 2020

Antibiotics	Streptococcus pneumoniae		Streptococcus viridians		Staphylococcus aureus		Coagulase Negative Staphylococci		Listeria monocytogenes
	S (%)	R (%)	S (%)	R (%)	S (%)	R (%)	S (%)	R (%)	S (%)	R (%)
Ampicillin	6 (100)	0 (0)	N/A	N/A	1 (33.3)	2 (66.7)	N/A	N/A	1 (100)	0 (0)
Ceftriaxone	6 (100)	0 (0)	N/A	N/A	3 (100)	0 (0)	1 (100)	0 (0)	1 (100)	0 (0)
Chloramphenicol	7 (77.8)	2 (22.2)	0 (0)	1 (100)	0 (0)	1 (100)	N/A	N/A	1 (100)	0 (0)
Ciprofloxacin	5 (83.3)	1 (16.7)	N/A	N/A	2 (66.7)	1 (33.3)	N/A	N/A	N/A	N/A
Gentamicin	1 (25)	3 (75)	0 (0)	1 (100)	N/A	N/A	N/A	N/A	1 (100)	0 (0)
PencillinG	11 (100)	0 (0)	0 (0)	1 (100)	1 (50)	1 (50)	1 (100)	0 (0)	N/A	N/A
Cotrimoxazole	2 (33.3)	4 (66.7)	N/A	N/A	0 (0)	3 (100)	1 (100)	0 (0)	N/A	N/A
Amoxicillin	3 (100)	0 (0)	N/A	N/A	2 (66.7)	1 (33.3)	N/A	N/A	1 (100)	0 (0)
Norfloxacin	3 (100)	0 (0)	N/A	N/A	1 (100)	0 (0)	N/A	N/A	N/A	N/A
Vancomycin	7 (87.5)	1 (12.5)	1 (100)	0 (0)	2 (66.7)	1 (33.3)	1 (100)	0 (0)	1 (100)	0 (0)
Clindamycin	N/A	N/A	N/A	N/A	3 (100)	0 (0)	N/A	N/A	1 (100)	0 (0)
Cefoxitin	2 (100)	0 (0)	N/A	N/A	3 (100)	0 (0)	N/A	N/A	N/A	N/A
Tetracycline	3 (42.9)	4 (57.1)	N/A	N/A	1 (33.3)	2 (66.7)	0 (0)	1 (100)	N/A	N/A
Erythromycin	4 (80)	1 (20)	N/A	N/A	4 (66.7)	2 (33.3)	0 (0)	1 (100)	N/A	N/A
Cefuroxime	1 (100)	0 (0)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Kanamycin	1 (100)	0 (0)	N/A	N/A	N/A	N/A	N/A	N/A	1 (100)	N/A

Abbreviations: S, sensitive; R, resistant; NLF, non-lactose fermenter; N/A, not applicable.